Anti-SARS-CoV-2 monoclonal antibodies for the treatment of mild-to-moderate COVID-19 in multiple sclerosis: A retrospective cohort study

Autor: Jin, Harry, Geiger, Caroline, Jessop, Nikki, Pedotti, Rosetta, Raposo, Catarina, Whitley, Louise, Brown, Jeffrey S., Muros-Le Rouzic, Erwan
Zdroj: In Multiple Sclerosis and Related Disorders November 2023 79
Databáze: ScienceDirect